Abstract:Background Individual-level blood pressure (BP) variability, independent of mean BP levels, has been associated with increased risk for cardiovascular events in cohort studies and clinical trials using standardized BP measurements. The extent to which BP variability relates to cardiovascular risk in the real-world clinical practice setting is unclear. We sought to determine if BP variability in clinical practice is associated with adverse cardiovascular outcomes using clinically generated data from the electronic health record (EHR). Methods We identified 42,482 patients followed continuously at a single academic medical center in Southern California between 2013 and 2019 and calculated their systolic and diastolic BP variability independent of the mean (VIM) over the first 3 years of the study period. We then performed multivariable Cox proportional hazards regression to examine the association between VIM and both composite and individual outcomes of interest (incident myocardial infarction, heart failure, stroke, and death). Findings Both systolic (HR, 95% CI 1.22, 1.17-1.28) and diastolic VIM (1.24, 1.19-1.30) were positively associated with the composite outcome, as well as all individual outcome measures. These findings were robust to stratification by age, sex and clinical comorbidities. In sensitivity analyses using a time-shifted follow-up period, VIM remained significantly associated with the composite outcome for both systolic (1.15, 1.11-1.20) and diastolic (1.18, 1.13-1.22) values. Interpretation VIM derived from clinically generated data remains associated with adverse cardiovascular outcomes and represents a risk marker beyond mean BP, including in important demographic and clinical subgroups. The demonstrated prognostic ability of VIM derived from non-standardized BP readings indicates the utility of this measure for risk stratification in a real-world practice setting, although residual confounding from unmeasured variables cannot be excluded. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.

Blood pressure variability: no longer a mASCOT for research nerds

Blood pressure variability: clinical relevance and application

Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases

How important is blood pressure variability?

Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper∗

Blood pressure and its variability: classic and novel measurement techniques

Blood Pressure Variability and Therapeutic Implications in Hypertension and Cardiovascular Diseases

Blood Pressure Variability Predicts Poor Outcomes in Acute Stroke Patients Without Thrombolysis: a Systematic Review and Meta-Analysis.

Blood Pressure Variability in Clinical Practice: Past, Present and the Future

Blood Pressure Variability is Associated with Increased Risk of Heart Disease and Death, Study Finds:

Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: A systematic review and meta‐analysis

Blood pressure variability predicts cognitive decline in Alzheimer's disease patients

Prognostic Relevance of Short-Term Blood Pressure Variability. The Spanish ABPM Registry

Variability Independent of Mean Blood Pressure As a Real-World Measure of Cardiovascular Risk

Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT

Associations between Five-Year Blood Pressure Variability and Risk of Cardiovascular Events and Mortality

Blood pressure variability: A potential marker of aging

Variability--the drama of the circulation

Blood Pressure Variability and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.

Blood pressure variability in acute stroke: Risk factors and association with functional outcomes at 1 month

Doubts and Difficulties in Studying Blood Pressure Variability.